Polymyositis and dermatomyositis risk factors: Difference between revisions
Jump to navigation
Jump to search
| Line 36: | Line 36: | ||
===Less Common Risk Factors=== | ===Less Common Risk Factors=== | ||
*Less common risk factors in the development of polymyositis and dermatomyositis include: | *Less common risk factors in the development of polymyositis and dermatomyositis include: | ||
**Tobacco smoking<ref name="SchiffenbauerFaghihi-Kashani2018">{{cite journal|last1=Schiffenbauer|first1=Adam|last2=Faghihi-Kashani|first2=Sara|last3=O’Hanlon|first3=Terrence P.|last4=Flegel|first4=Willy A.|last5=Adams|first5=Sharon D.|last6=Targoff|first6=Ira N.|last7=Oddis|first7=Chester V.|last8=Ytterberg|first8=Steven R.|last9=Aggarwal|first9=Rohit|last10=Christopher-Stine|first10=Lisa|last11=Shamim|first11=Ejaz A.|last12=Dellaripa|first12=Paul F.|last13=Danoff|first13=Sonye K.|last14=Mammen|first14=Andrew|last15=Miller|first15=Frederick W.|title=The impact of cigarette smoking on the clinical and serological phenotypes of polymyositis and dermatomyositis|journal=Seminars in Arthritis and Rheumatism|year=2018|issn=00490172|doi=10.1016/j.semarthrit.2018.02.003}}</ref> | **Tobacco smoking (association with rise in anti-Jo-1 autoantibody)<ref name="SchiffenbauerFaghihi-Kashani2018">{{cite journal|last1=Schiffenbauer|first1=Adam|last2=Faghihi-Kashani|first2=Sara|last3=O’Hanlon|first3=Terrence P.|last4=Flegel|first4=Willy A.|last5=Adams|first5=Sharon D.|last6=Targoff|first6=Ira N.|last7=Oddis|first7=Chester V.|last8=Ytterberg|first8=Steven R.|last9=Aggarwal|first9=Rohit|last10=Christopher-Stine|first10=Lisa|last11=Shamim|first11=Ejaz A.|last12=Dellaripa|first12=Paul F.|last13=Danoff|first13=Sonye K.|last14=Mammen|first14=Andrew|last15=Miller|first15=Frederick W.|title=The impact of cigarette smoking on the clinical and serological phenotypes of polymyositis and dermatomyositis|journal=Seminars in Arthritis and Rheumatism|year=2018|issn=00490172|doi=10.1016/j.semarthrit.2018.02.003}}</ref> | ||
**Maternal smoking during pregnancy (risk factor for a juvenile dermatomyositis) | **Maternal smoking during pregnancy (risk factor for a juvenile dermatomyositis) | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Revision as of 16:26, 11 April 2018
|
Polymyositis and dermatomyositis Microchapters |
|
Differentiating Polymyositis and dermatomyositis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Polymyositis and dermatomyositis risk factors On the Web |
|
American Roentgen Ray Society Images of Polymyositis and dermatomyositis risk factors |
|
Risk calculators and risk factors for Polymyositis and dermatomyositis risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sadaf Sharfaei M.D.[2]
Overview
Common risk factors in the development of polymyositis and dermatomyositis include environmental factors such as infection, malignancy, and drug toxicities from statins or immune checkpoint inhibitors.
Risk Factors
- Common risk factors in the development of polymyositis and dermatomyositis include environmental factors such as infection, malignancy, and drug toxicities from statins or immune checkpoint inhibitors.[1]
Common Risk Factors
- Common risk factors in the development of polymyositis and dermatomyositis include:
- Viral infections such as:
- Coxsackie B virus
- Parvovirus
- Enterovirus
- Human T-cell lymphotropic virus (HTLV-1)
- Human immunodeficiency virus (HIV)
- Epstein-Barr virus (EBV)
- Adenovirus
- Influenza
- Malignancy such as:
- Ovarian
- Lung
- Gastric
- Colorectal
- Pancreatic
- Non-Hodgkin’s lymphoma
- Drugs such as:
- Statins
- Immune checkpoint inhibitors such as:
- Ipilimumab
- Pembrolizumab
- Interferon-alpha
- IL-2 therapy
- Viral infections such as:
Less Common Risk Factors
- Less common risk factors in the development of polymyositis and dermatomyositis include:
- Tobacco smoking (association with rise in anti-Jo-1 autoantibody)[2]
- Maternal smoking during pregnancy (risk factor for a juvenile dermatomyositis)
References
- ↑ Adler BL, Christopher-Stine L (February 2018). "Triggers of inflammatory myopathy: insights into pathogenesis". Discov Med. 25 (136): 75–83. PMID 29579414.
- ↑ Schiffenbauer, Adam; Faghihi-Kashani, Sara; O’Hanlon, Terrence P.; Flegel, Willy A.; Adams, Sharon D.; Targoff, Ira N.; Oddis, Chester V.; Ytterberg, Steven R.; Aggarwal, Rohit; Christopher-Stine, Lisa; Shamim, Ejaz A.; Dellaripa, Paul F.; Danoff, Sonye K.; Mammen, Andrew; Miller, Frederick W. (2018). "The impact of cigarette smoking on the clinical and serological phenotypes of polymyositis and dermatomyositis". Seminars in Arthritis and Rheumatism. doi:10.1016/j.semarthrit.2018.02.003. ISSN 0049-0172.